# The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer

> **NCT06698679** · — · RECRUITING · sponsor: **Shengjing Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT06698679
- **Lead sponsor:** Shengjing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-15
- **Primary completion:** 2031-06-30
- **Final completion:** 2031-10-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06698679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06698679, "The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06698679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*